Ładuje się......
From palliative to curative treatment - stage IV mucinous adenocarcinoma, successfully treated with metronomic capecitabine in combination with Bevacizumab and surgery- a case report
BACKGROUND: Mucinous adenocarcinoma (MAC) represents 6-19 % of all colorectal carcinoma. It is associated with poorer response to chemotherapy and chemoradiotherapy. CASE PRESENTATION: A 27-year-old Swedish woman presented with stomach pain and weight loss, and was diagnosed with locally advanced MA...
Zapisane w:
Wydane w: | BMC Cancer |
---|---|
Główni autorzy: | , , , , , , |
Format: | Artigo |
Język: | Inglês |
Wydane: |
BioMed Central
2015
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4640161/ https://ncbi.nlm.nih.gov/pubmed/26555668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1908-3 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|